Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-09-20
2005-09-20
Berch, Mark L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S364000
Reexamination Certificate
active
06946467
ABSTRACT:
The compound 1-(indole-6-carbonyl-D-phenylglycinyl)-4-(1-methylpiperidin-4-yl)piperazine and physiologically-tolerable salts thereof are factor Xa inhibitors useful for the treatment of thrombotic disorders.
REFERENCES:
patent: 5346907 (1994-09-01), Kerwin et al.
patent: 796866 (1997-09-01), None
patent: WO 91/00725 (1991-01-01), None
patent: WO 97/49404 (1997-12-01), None
patent: WO 98/47876 (1998-10-01), None
patent: WO 99/00121 (1999-01-01), None
patent: WO 99/00126 (1999-01-01), None
patent: WO 99/00127 (1999-01-01), None
patent: WO 99/00128 (1999-01-01), None
patent: WO 99/11657 (1999-03-01), None
patent: WO 99/11658 (1999-03-01), None
patent: WO 00/39092 (2000-07-01), None
patent: WO 00/39111 (2000-07-01), None
patent: WO 00/39117 (2000-07-01), None
patent: WO 00/39118 (2000-07-01), None
patent: WO 00/71493 (2000-11-01), None
patent: WO 00/71507 (2000-11-01), None
patent: WO 00/71508 (2000-11-01), None
patent: WO 00/76971 (2000-12-01), None
patent: WO 00/76970 (2002-12-01), None
patent: WO 00/77027 (2002-12-01), None
Jones, Stuart D, et al., Bioorganic & Medicinal Chemistry Letters 11 (2001) 733-736.
Camp Nicholas Paul
Engel David Birenbaum
Guzzo Peter Robert
Jones Stuart Donald
Liebeschuetz John Walter
Berch Mark L.
Eli Lilly and Company
Habte Kahsay
Hay Martin A
LandOfFree
Serine protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Serine protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Serine protease inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3425769